In this study, clinical specimens were analyzed, and in vitro experiments were conducted to confirm that the miR‐125b‐5p/STAT3 axis could inhibit the invasiveness, migration, and stemness of HCC via the wnt/β‐Catenin pathway. The gene discussed is STAT3; the disease is hepatocellular carcinoma.